Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases

被引:2
|
作者
Florez, Marcus A. [1 ]
De, Brian [1 ]
Chapman, Bhavana, V [1 ]
Prayongrat, Anussara [1 ]
Thomas, Jonathan G. [2 ]
Beckham, Thomas H. [1 ]
Wang, Chenyang [1 ]
Yeboa, Debra N. [1 ]
Bishop, Andrew J. [1 ]
Briere, Tina [3 ]
Amini, Behrang [4 ]
Li, Jing [1 ]
Tatsui, Claudio E. [2 ]
Rhines, Laurence D. [2 ]
Ghia, Amol J. [1 ,5 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Neurol Surg, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Musculoskeletal Imaging, Houston, TX USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, 1515 Holcombe Blvd,Unit 1202, Houston, TX 77030 USA
来源
RADIATION ONCOLOGY JOURNAL | 2023年 / 41卷 / 01期
基金
美国国家卫生研究院;
关键词
Radiosurgery; Re-irradiation; Radiotherapy dosage; Local neoplasm recurrence; Neoplasm metastasis; BODY RADIATION-THERAPY; RADIOTHERAPY; RISK; SURVIVAL; TOXICITY; OUTCOMES; FAILURE;
D O I
10.3857/roj.2022.00353
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: There has been limited work assessing the use of re-irradiation (re-RT) for local failure fol-lowing stereotactic spinal radiosurgery (SSRS). We reviewed our institutional experience of conven-tionally-fractionated external beam radiation (cEBRT) for salvage therapy following SSRS local failure. Materials and Methods: We performed a retrospective review of 54 patients that underwent salvage conventional re-RT at previously SSRS-treated sites. Local control following re-RT was defined as the absence of progression at the treated site as determined by magnetic resonance imaging. Results: Competing risk analysis for local failure was performed using a Fine-Gray model. The median follow-up time was 25 months and median overall survival (OS) was 16 months (95% confidence in-terval [CI], 10.8-24.9 months) following cEBRT re-RT. Multivariable Cox proportional-hazards analysis revealed Karnofsky performance score prior to re-RT (hazard ratio [HR] = 0.95; 95% CI, 0.93- 0.98; p = 0.003) and time to local failure (HR = 0.97; 95% CI, 0.94-1.00; p = 0.04) were associated with lon-ger OS, while male sex (HR = 3.92; 95% CI, 1.64-9.33; p = 0.002) was associated with shorter OS. Local control at 12 months was 81% (95% CI, 69.3-94.0). Competing risk multivariable regression revealed radioresistant tumors (subhazard ratio [subHR] = 0.36; 95% CI, 0.15-0.90; p = 0.028) and epidural disease (subHR = 0.31; 95% CI, 0.12-0.78; p =0.013) were associated with increased risk of local failure. At 12 months, 91% of patients maintained ambulatory function. Conclusion: Our data suggest that cEBRT following SSRS local failure can be used safely and effec-tively. Further investigation is needed into optimal patient selection for cEBRT in the retreatment set-ting.
引用
收藏
页码:12 / 22
页数:11
相关论文
共 50 条
  • [1] Second Re-irradiation of Brain Metastases: A Review of Studies Involving Stereotactic Radiosurgery
    Nieder, Carsten
    Yobuta, Rosalba
    Mannsaker, Bard
    CUREUS, 2018, 10 (12):
  • [2] Stereotactic radiosurgery for the treatment of bulky spine metastases
    Kowalchuk, Roman O.
    Waters, Michael R.
    Richardson, K. Martin
    Spencer, Kelly M.
    Larner, James M.
    Sheehan, Jason P.
    McAllister, William H.
    Kersh, C. R.
    JOURNAL OF NEURO-ONCOLOGY, 2020, 148 (02) : 381 - 388
  • [3] Efficacy and toxicity of re-irradiation spine stereotactic body radiotherapy with respect to irradiation dose history
    Ito, Kei
    Ogawa, Hiroaki
    Nakajima, Yujiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (02) : 264 - 270
  • [4] Re-irradiation with Radiosurgery for Recurrent Glioblastoma Multiforme
    Torok, J. A.
    Wegner, R. E.
    Mintz, A. H.
    Heron, D. E.
    Burton, S. A.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2011, 10 (03) : 253 - 258
  • [5] Second re-irradiation: A delicate balance between safety and efficacy
    Nieder, Carsten
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2019, 58 : 155 - 158
  • [6] Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife
    Adachi, Kana
    Hayashi, Kazuhiko
    Kagawa, Naoki
    Kinoshita, Manabu
    Sumida, Iori
    Akino, Yuichi
    Shiomi, Hiroya
    Tamari, Keisuke
    Suzuki, Osamu
    Hirayama, Ryuichi
    Kijima, Noriyuki
    Isohashi, Fumiaki
    Seo, Yuji
    Otani, Keisuke
    Kishima, Haruhiko
    Ogawa, Kazuhiko
    ANTICANCER RESEARCH, 2019, 39 (06) : 2935 - 2940
  • [7] Brain metastases re-irradiation: safety and efficacy in a monoinstitutional experience
    Fodor, Andrei
    Deantoni, Chiara Lucrezia
    Torrisi, Miriam
    Roncelli, Francesca
    Bailo, Michele
    Gagliardi, Filippo
    Snider, Silvia
    Gigliotti, Carmen
    Dell'Oca, Italo
    Perna, Lucia
    Broggi, Sara
    Del Vecchio, Antonella
    Barzaghi, Raffaella
    Mortini, Pietro
    Di Muzio, Nadia Gisella
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S889 - S891
  • [8] Stereotactic Radiosurgery Re-Irradiation for Recurrent Glioblastoma: A Single Institution Experience
    Duriseti, Sai
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : E8 - E9
  • [9] Re-irradiation after stereotactic body radiotherapy for spine metastases from hepatocellular carcinoma: a case report
    BalajiSubramanian, Sitaraman
    Sathiya, Krishnamoorthy
    Balaji, Karunakaran
    Thirunavukarasu, Moorthi
    Phanikiran, Surparaju
    Rela, Mohamed
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2021, 26 (06) : 1060 - 1065
  • [10] Re-Irradiation of Progressive Brain Metastases After Whole Brain Radiotherapy: Outcome of Stereotactic Radiosurgery
    Ozseker, Naciye Isik
    Kocak, Mihriban
    Mayadagli, Alpaslan
    Gemici, Cengiz
    Gul, Sule
    Gedik, Duygu
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2012, 29 (01): : 82 - 91